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ABSTRACT
Background: The objective of the study was to assess the effect of prophylactic antibiotics on the
outcome of bone augmentation and subsequent dental implant placement by combining the recom-
mended quality assessment methods for systematic reviews and primary studies.
Materials and methods: This is a complex systematic review in which systematic reviews as well as
primary studies are scrutinised. A search of Medline (OVID), The Cochrane Library (Wiley) and EMBASE,
PubMed and Health technology assessment (HTA) organisations as-well as a complementary hand-
search was carried out. Selected primary studies were assessed using GRADE. Each study was reviewed
by three authors independently.
Results: Abstract screening yielded six potential systematic reviews allocated for full-text inspection.
A total of ten primary studies were read in full-text. No relevant systematic reviews regarding the topic
of this article were found. The quality assessment resulted in two primary studies with a moderate risk
of bias. Of the two studies with a moderate risk of bias, one compared a single dose of clindamycin
600mg preoperatively with the same preoperative dose followed by four doses of 300mg every 6 h.
The second study compared a single dose prophylaxis of two different types of antibiotic compounds.
Conclusion: In conclusion, the scientific evidence regarding the use of antibiotic prophylaxis for reduc-
ing the risk of infection in conjunction with bone augmentation procedures during dental implant
placement is very limited. The infection rate as compared to nonusage of prophylactic antibiotics,
selection of the most suitable compound, and the optimal duration of prophylactic treatment is
still unknown.
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Antibiotic resistance is considered the largest threat to mod-
ern health care as many treatment options are dependent
on effective antibiotics [1]. Some parts of the world have
entered the postantibiotic era where the efficacy of antibiot-
ics can no longer be safely predicted [2]. An important meas-
ure to fight this development is restrictive antibiotic
utilisation [3]. The stated correlation between increasing rates
of antibiotic resistance and antibiotic consumption is unchal-
lenged and well supported [4–7]. The suggestion that short-
term antibiotic treatments would pose a reduced risk for
antibiotic resistance is not well established [8]. Also a single
dose of amoxicillin can select for resistant strains in the oral
cavity [9]. For each indication and patient, the potential risk
with antibiotic prescription must be weighed against the
putative benefits. The antibiotics prescribed in dentistry sum
up to approximately 5–10% of the total usage in health care
according to reports from Europe and the USA thus contribu-
ting to a substantial part of the consumption [10–14].
Insertion of dental implants is a commonly used thera-
peutic option for replacement of missing teeth and displays
excellent success rates [15–24]. When the residual bone vol-
ume is insufficient it is common to perform bone augmenta-
tion procedures prior to, or in conjunction with, implant
placement [25–27].
Considering the large amount of patients subjected to
this therapy, the antibiotic used during these procedures
may significantly contribute to the overall usage especially
if a prophylaxis regimen beyond the day of surgery is pre-
scribed. However, the scientific evidence to support this
routine is unclear. A literature review regarding antibiotic
prophylaxis in surgery included over 600 references but
could not find support for antibiotic prescription beyond
the day of surgery for prevention of postoperative infec-
tions in any of the studied surgical fields [28]. In the light
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of this, it is reasonable to question whether prolonging the
antibiotics beyond the day of surgery during bone augmen-
tation procedures is a motivated procedure.
The number of published systematic reviews has
increased significantly in recent years [29,30]. This provides
a valuable mean to synthesise current knowledge within a
particular field. However, a poorly performed systematic
review may be misleading giving the incorrect impression
of sound conclusions. It is therefore of great importance
that systematic reviews are performed according to high
standards and subjected to independent quality control
similar to the assessment of original research [31,32].
AMSTAR is a validated and reliable tool that is increasingly
being used for evaluation of systematic reviews [33–35]. It
has been suggested that when reviewing literature pre-
existing reviews should, in concert with the primary study,
be incorporated into a complex systematic review [36]. A
strict predefined PICO (population, intervention, control
and outcome/observation) is mandatory in this process, as
well as quality assessment by independent reviewers,
resulting in strict inclusion only of systematic reviews of
high quality.
The aim of the current study was to assess the available
scientific literature regarding the efficacy of prophylactic anti-
biotics at bone augmentation procedures and subsequent
dental implant placement. Including both staged bone aug-




The objective of the study was to assess the effect of antibi-
otics on frequency of postoperative infections after bone
augmentation in conjunction with dental implant placement,
both staged bone augmentation and bone augmentation
with simultaneous implant placement.
Criteria for considering studies
The predefined study population, intervention, the compari-
son of therapies, and outcome parameters for the eligible
studies are summarised in Table 1. Additionally, inclusion
and exclusion criteria for systematic reviews and primary
studies are presented in Table 1.
Search strategies
Two of the authors (AK and ANA) and two information spe-
cialists (from Karolinska Institutet University library) per-
formed the literature search. The following databases were
searched until October 26, 2015: Medline (OVID), The
Cochrane Library (Wiley) and EMBASE (embase.com), PubMed
(nonindexed articles). No limitation regarding start year were
used. The search was initially performed without any filters
for the search of primary studies and then repeated once
more with a filter for systematic reviews.
For the detection of recent publications, a complementary
search was undertaken in PubMed on August 27, 2018.
The additional search did not use any filters and all new
findings from both primary studies as well as systematic
reviews were screened.
The search terms used for the databases are summarised
in Table 2. Search terms used were; e.g. alveolar ridge aug-
mentation, alveolar bone grafting, dental implantation,
implant-supported, sinus floor augmentation, sinus floor
augmentation, bone graft augmentation, dental implants,
antibiotic prophylaxis (Table 2).
Health technology assessment (HTA) organisations were
searched regarding the effect of antibiotics versus no treat-
ment or placebo on the outcome of bone augmentation in
conjunction with dental implant installation until October 30
2015: National Institute for Health and Care Excellence
(NICE), http://www.nice.org.uk/; CADTH, http://www.cadth.ca/;
CRD database, http://www.crd.york.ac.uk/CRDWeb/;
Kunnskapssenteret, http://www.kunnskapssenteret.no/home?-
language=english, and ASERNIP-S http://www.surgeons.org/
for-health-professionals/audits-and-surgical-research/asernip-
s/publications/. The reference lists of all the eligible studies
Table 1. Parameters of interest regarding eligible studies including inclusion
and exclusion criteria for both systematic reviews and primary studies.
P Patients subjected to bone augmentation procedures with
or without simultaneous implant placement
I Antibiotics on day of surgery i.e. short-termed prophylaxis
Antibiotics more than day of surgery i.e. ”extended” prophylaxis
Head-to-head comparison of different antibiotic compounds
or regiments
C No antibiotic treatment
Placebo
Other nonantibiotic treatment e.g. such as antibacterial rinsing
Other/comparing antibiotic treatment (alternative compound)
Same compound, different dose/duration
O Infection (primary)




























Any study type except RCT
Lack of follow-up
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Table 2. Search strategy.
Database Search strategy
Medline (Ovid) 1. Alveolar Ridge Augmentation/
2. Alveolar Bone Grafting/
3. Guided Tissue Regeneration, Periodontal/
4. exp Dental Implantation/
5. Dental Prosthesis, Implant-Supported/
6. Sinus Floor Augmentation/
7. Alveolar Ridge Augmentation.tw,kf.
8. Sinus Floor Augmentation.tw,kf.
9. Bone Graft Augmentation.tw,kf.
10. or/1-9
11. ((bone or tissue) adj3 (alveolar or dental or intraoral or intra-oral or jaw or mandible or maxilla or oral or periodont or ridge or sinus




14. ((bone or tissue) adj2 (allograft or allogen or alloplast or implant or heterograft or substitute or transplant or xenograft or
xenogen) adj3 (alveolar or dental or intraoral or intra-oral or jaw or mandible or maxilla or periodont or oral or ridge or sinus or
tooth socket)).tw,kf.
15. or/13-14
16. 12 or 15
17. exp Anti-Bacterial Agents/
18. Antibiotic Prophylaxis/
19. (antibiotic or cephalosporin or cefazolin or cefuroxime or amox?cillin or clindam?cin or penicillin or levofloxacin). tw,kf.
20. or/17–19
21. 16 and 20
The Cochrane
Library (Wiley)
#1: ((alveolar or dental or intraoral or intra-oral or jaw or mandible or maxilla or oral or periodont or ridge or sinus or tooth socket) near/3
(augmentation or elevation or graft or implantation or osseointegration or preservation or regenerat or reconstruct or
transplantation)):ti,ab
#2: ((allograft or allogen or alloplast or implant or heterograft or substitute or transplant or xenograft or xenogen) near/3 (alveolar or
dental or intraoral or intra-oral or jaw or mandible or maxilla or periodont or oral or ridge or sinus or tooth socket)):ti,ab
#3: #1 or #2
#4: (antibiotic or cephalosporin or cefazolin or cefuroxime or amoxicillin or amoxycillin or clindamycin or clindamicin or penicillin or
levofloxacin):ti,ab
#5: #3 AND #4
EMBASE
(www.embase.com)
#20: #15 AND #19
#19: #16 OR #17 OR #18
#18: antibiotic:ab,ti OR cephalosporin:ab,ti OR cefazolin:ab,ti OR cefuroxime:ab,ti OR amoxicillin:ab,ti OR amoxycillin:ab,ti OR clindamycin:ab,ti
OR clindamycin:ab,ti OR penicillin:ab,ti OR levofloxacin:ab,ti
#17: ’antibiotic prophylaxis’/de
#16: ’antibiotic agent’/exp
#15: #11 OR #14
#14: #12 OR #13
#13: ((bone OR tissue) NEAR/2 (allograft OR allogen
OR alloplast OR implant OR heterograft OR substitute OR transplant OR xenograft OR xenogen) NEAR/3 (alveolar OR dental OR intraoral
OR ’intra-oral’ OR jaw OR mandible OR maxilla OR oral OR ridge OR sinus OR ’tooth socket’)):ab,ti
#12: ’tooth implant’/de
#11: #9 OR #10
#10: ((bone OR tissue) NEAR/3 (alveolar OR dental OR intraoral OR ’intra-oral’ OR jaw OR mandible OR maxilla OR oral OR ridge OR sinus OR
’tooth socket’) NEAR/3 (augmentation OR elevation OR graft OR implantation OR osseointegration OR preservation OR regenerat OR
reconstruct OR transplantation)):ab,ti
#9: #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8
#8: (guided NEXT/1 tissue NEXT/1 regeneration NEXT/4 periodont):ab,ti
#7: bone NEXT/1 graft NEXT/1 augmentation):ab,ti
#6: (sinus NEXT/1 floor NEXT/1 augmentation):ab,
#5: (alveolar NEXT/1 ridge NEXT/1 augmentation):ab,
#4: ’sinus floor augmentation’/de
#3: ’tooth implantation’/de




#6: #5 NOT medline[sb]
#5: #3 AND #4
#4: ((antibiotic[Title/Abstract] OR cephalosporin[Title/Abstract] OR cefazolin[Title/Abstract] OR cefuroxime[Title/Abstract] OR amoxicillin[Title/
Abstract] OR amoxycillin[Title/Abstract] OR clindamycin[Title/Abstract] OR clindamycin[Title/Abstract] OR penicillin[Title/Abstract] OR
levofloxacin[Title/Abstract]))
#3: #1 OR #2
#2: ((((bone[Title/Abstract] OR tissue[Title/Abstract])) AND (allograft[Title/Abstract] OR allogen[Title/Abstract] OR alloplast[Title/Abstract] OR
implant[Title/Abstract] OR heterograft[Title/Abstract] OR substitute[Title/Abstract] OR transplant[Title/Abstract] OR xenograft[Title/Abstract]
OR xenogen[Title/Abstract])) AND (alveolar[Title/Abstract] OR dental[Title/Abstract] OR intraoral[Title/Abstract] OR intra-oral[Title/Abstract] OR
jaw[Title/Abstract] OR mandible[Title/Abstract] OR maxilla[Title/Abstract] OR periodont[Title/Abstract] OR oral[Title/Abstract] OR ridge[Title/
Abstract] OR sinus[Title/Abstract] OR “tooth socket”[Title/Abstract]))
#1: ((((bone[Title/Abstract] OR tissue[Title/Abstract])) AND (allograft[Title/Abstract] OR allogen[Title/Abstract] OR alloplast[Title/Abstract] OR
implant[Title/Abstract] OR heterograft[Title/Abstract] OR substitute[Title/Abstract] OR transplant[Title/Abstract] OR xenograft[Title/Abstract]
OR xenogen[Title/Abstract])) AND (alveolar[Title/Abstract] OR dental[Title/Abstract] OR intraoral[Title/Abstract] OR intra-oral[Title/Abstract] OR
jaw[Title/Abstract] OR mandible[Title/Abstract] OR maxilla[Title/Abstract] OR periodont[Title/Abstract] OR oral[Title/Abstract] OR ridge[Title/
Abstract] OR sinus[Title/Abstract] OR “tooth socket”[Title/Abstract]))
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were hand-searched for potential complementary studies.
The search was not restricted by language. However,
retrieved papers in a language other than English, German,
French, or Swedish were excluded.
Study selection
Eligible studies were included in accordance with the inclu-
sion/exclusion criteria. AK (first author) went over the
retrieved list of publications and performed a crude exclu-
sion of irrelevant publications based on their title. In case of
uncertainty, a study remained included until the next selec-
tion step, which consisted of an examination of abstracts.
The abstracts were read independently in duplicate by three
reviewers, either BL, AK and ST or MH, ANA and BK. Selected
primary studies and systematic reviews were read in full-text
by three reviewers each, respectively. Any disagreement dur-




No systematic reviews were left for quality assessment, due
to out of topic reason. Had there been any systematic
reviews to review the quality of the studies would have been
assessed according to Mejare 2015 [37], based on AMSTAR
assessment items [33].
Primary studies
The quality of the included primary studies was assessed
using a protocol for assessment of randomised studies [38].
The quality assessment protocol focus on the risk of bias in
individual studies and specific outcomes as well as the over-
all quality of evidence.
Quality of evidence
The scientific quality of the evidence in the primary studies
was graded according to GRADE (GRADing quality of
Evidence and strength of recommendations) and set as high,
moderate, low, and very low [39] (Table 3). GRADE have 4
steps of evidence grading. The system was developed by the
GRADE working group. GRADE is used by e.g. World Health
Organization (WHO), NICE, Cochrane Collaboration and
British Medical Journal (BMJ).
Data extraction
Systematic reviews
No systematic reviews remained for data extraction due to
out of topic reason. Data extraction from the systematic
reviews would have been the following: objectives, main
results, authors’ estimated level of evidence, and knowledge
gaps according to authors.
Primary studies
Data was extracted from the primary studies regarding num-
ber of included patients, age, gender distribution, length of
follow-up, type of intervention, type of control treatment,
and relevant treatment outcomes.
Results
Literature search and study selection
The search resulted in 1155 titles after deduplication. The
results include both primary studies and systematic reviews
(n¼ 150). Search strategy, presented for each database, is
shown in Table 1. The search of HTA organisations did not
yield any further studies. Flow-charts of the screening pro-
cess for primary studies and systematic reviews are described
in Figures 1 and 2, respectively.
The additional search on August 27, 2018 added 372 new
articles: all were screened for both systematic reviews and
primary studies.
Systematic reviews
Abstract screening yielded six potential systematic reviews
allocated for full-text inspection. The most common reason
for exclusion was that the study was out of topic (n¼ 4) (Out
of topic means that the study was not within our PICO, e.g.
if the article did not mention bone augmentation in associ-
ation with implants and antibiotics).The second most com-
mon reason for exclusion was that the study was not
considered a systematic review (n¼ 2) [40–45] (Table 4).
Primary studies
A total of ten primary studies were read in full-text. At this
stage another six studies were excluded, yielding four pri-
mary studies included for further analysis. Primary studies
that were regarded as nonrelevant to the current systematic
review were excluded at this stage and reason for exclusion
were recorded (Table 5) [46–51]. Reason for exclusion could
be e.g. language, not a randomized controlled trial (RCT), or
a research question that was not correct.
Table 3. Significance of the four levels of evidence.
Quality level Current definition
High We are very confident that the true effect lies close to that of
the estimate of the effect
Moderate We are moderately confident in the effect estimate: The true
effect is likely to be close to the estimate of the effect, but
there is a possibility that it is substantially different
Low Our confidence in the effect estimate is limited: The true effect
may be substantially different from the estimate of the effect
Very low We have very little confidence in the effect estimate: The true
effect is likely to be substantially different from the estimate
of effect
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Quality assessment and data extraction
Systematic reviews
No systematic reviews were left for quality assessment and
data extraction due to out of topic reason.
Primary studies
The quality assessment resulted in two studies with a moder-
ate risk of bias, Figure 3 [52,53], and two studies with a high
risk of bias [54,55]. The main reason for the two studies
being regarded as having a high risk of bias was shortcom-
ings and uncertainties in the randomisation process. The first
of the two studies with a moderate risk of bias, Lindeboom
et al. [52], compared a single dose of clindamycin 600mg
preoperatively with the same preoperative dose followed by
four doses of 300mg every 6 h.
The second study, Lindeboom et al. [53], compared a sin-
gle dose prophylaxis of two different types of antibiotic com-
pounds (Table 6). Type of intervention and study population
characteristics for studies classified as being of low or moder-
ate risk of bias are also shown in Table 6. Outcome of pri-
mary studies classified as being of low or moderate risk of
bias are shown in Table 7. In the first study, Lindeboom
et al. [52], 2 of 62 patients in the intervention group (600mg
clindamycin 1 h preop.) developed a postoperative infection.
In the control group (clindamycin 24 h) 3 of 62 patients
developed a postoperative infection at receptor site. In the
second study, Lindeboom et al. [53], 4 of 75 patients in the
intervention group (2 g penicillin 1 h preop.) developed a
postoperative infection. In the control group (600mg clinda-
mycin 1 h preop.) 2 of 75 patients developed a postoperative
infection at receptor site (Table 7). Due to few events, statis-
tical analysis was not applicable. The two studies with a high
risk of bias are presented in Figure 4.
Publication bias and heterogeneity
Not applicable due to too few studies available to make a
meta-analysis.
Discussion
The results of the present systematic review illustrates that
there is a lack of existing scientific evidence on antibiotic
Figure 1. Flow chart, primary studies. From Moher et al. [31].
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prophylaxis for oral bone augmentation procedures in the
alveolar ridge and subsequent dental implant placement.
No data were available on implant placement with simul-
taneous bone augmentation. Since this procedure is fre-
quently used in implant dentistry, the lack of data for this
indication is observable and in need of further research on
the subject.
No data was available on any of the other parameters in
our PICO, in the included studies.
The study by Lindeboom et al. [52] compared the risk of
developing a postsurgical infection at the bone graft recep-
tor site between patients given a single dose of antibiotic
prophylaxis and patients receiving a more extended 24-h
dose of clindamycin. Although the study showed that there
was a difference in risk, albeit not a statistically significant
one, the number of postsurgical infections was low in both
groups. Therefore the outcome of a statistical comparison
between the two groups may be hampered by insufficient
power. In addition, Lindeboom et al. [53] found no signifi-
cant difference in the occurrence of postsurgical recipient
site infection when comparing two different antibiotic com-
pounds, penicillin and clindamycin used as a single dose of
antibiotic prophylaxis. The result of both the included studies
indicates that the wound infection rate when using a single
dose of prophylactic antibiotics was low.
There is very limited available evidence on antibiotic
prophylaxis on staged bone augmentation with intraoral
donor sites and the complete lack of evidence on staged
bone augmentation with extra-oral donor bone and
implant placement.
Figure 2. Flow chart, systematic reviews. From Moher et al. [31].
Table 4. Excluded systematic reviews.
Author Reason for exclusion
Chen et al. [40] Not a systematic review
Chrcanovic et al. [41] Out of topic
Esposito et al. [42] Out of topic
Lang et al. [43] Out of topic
Sharaf and Dodson [44] Not a systematic review
Waasdorp et al. [45] Out of topic
Table 5. Excluded primary studies read in full text.
References Reason for exclusion
Brennan et al. [46] Letter to editor
Chuvilkin et al. [47] Not in English
Cohen [48] Case series
Eickholz et al. [49] Not correct research question
Kulshrestha [50] Not correct research question
Ngeow [51] Letter to editor
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Due to the limited number of studies eligible for inclusion
in the present systematic review, we were not able to draw
a definite conclusion regarding whether prolonged antibiotic
prophylaxis is needed to reduce the risk of postoperative
infection during bone grafting procedures or if a single dose
is equally sufficient. Consequently, there is a gap in our
knowledge concerning the efficacy of antibiotic prophylaxis,
regardless of length, compared to no use of antibiotics for
prevention of potential postoperative infections after bone
grafting procedures. Only two primary studies fulfilling the
inclusion criteria were considered to be of moderate risk of
bias [52,53]. The other eligible primary studies (n¼ 2) were
rejected due to a high risk of bias [54,55]. The main reasons
for exclusion due to a high risk of bias were an unclear ran-
domisation process and allocation concealment, insufficiently
described blinding, and unclear outcome measures.
The core of the systematic review will always be the qual-
ity of the included primary studies. Therefore, it is of great
importance that RCTs should be designed, performed, and
reported in accordance with internationally recognised
Figure 3. Methodological assessment of included studies.





period Intervention Control Risk of bias comments
Lindeboom et al. (2005)
The Netherlands
n: 124 8 weeks 600mg clindamycin 1 h
prior surgery –placebo
capsules every 6 h for
24 h postoperatively
600mg clindamycin 1 h prior
surgery – 300mg
clindamycin every 6 h for
24 h postoperatively
Moderate risk of bias
Age: 18–59 years No published study protocol
Gender (m/f): 50/74 Somewhat unclear blinding
Augmentation: onlay
bone graft




Lindeboom et al. (2006)
The Netherlands
n: 150 8 weeks 2 g penicillin 1 h
prior surgery
600mg clindamycin 1 h
prior surgery
Moderate risk of bias
Age: 18–67 years No published study protocol
Gender (m/f): 52/98 Unclear randomization
Augmentation: onlay
bone graft




n: number of patients; m/f: male/female; g: gram; h: hour; preop: preoperative; postop: postoperative; mg: milligram.






ResultsPostoperative infection No. Postoperative infection No.
Lindeboom et al. (2005)
The Netherlands
Clindamycin 600mg 1 h preop 62 Clindamycin 24 h 62 RR – 0.67
2 Patients with infection at receptor site 3 Patients with infection at receptor site
Lindeboom et al. (2006)
The Netherlands
Penicillin 2 g 1 h preop 75 Clindamycin 600mg 1 h preop 75 RR – 2.00
4 Patients with infection at receptor site 2 Patients with infection at receptor site
No: number of patients; g: gram; preop: preoperative; hr: hour; postop: postoperative; mg: milligram; RR: risk ratio.
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standards such as the CONSORT statement, in order for
accurate conclusions to be drawn [56]. Since the quality of
reviews differs significantly, one needs to approach the
assessment of systematic reviews in the same way as the
current study has approached it [36].
While there are many published systematic reviews on
the use of antibiotics in dental implant surgery, we were not
able to find any that fulfilled our inclusion criteria. For
example, this was the case with a systematic review initially
allocated, evaluating survival and success rates of implants
placed into fresh extraction sockets, since data of prophylac-
tic antibiotics given in bone grafting procedures was not
separately compared [43].
In addition, RCTs on the topic of antibiotics and bone
augmentation procedures are lacking. Generally, large num-
bers of systematic reviews are seen in fields where primary
studies are sparse and the results contradictory. This
repeated effort to extract and summarise data is probably
due to the desire to synthesise solid evidence despite diver-
gent results and/or underpowered primary studies. The phe-
nomenon as such indicates a further need for high-quality
research. The results of the present study thus serve to
emphasise the fact that one needs to be vigilant about
drawing conclusions from such published systematic reviews.
Traditionally, antibiotic prophylaxis has been administered
either pre-, peri-, or post-operative to prevent infection
developing at the surgical wound site. A placebo-controlled
double blind pilot study comparing the prophylactic use of
phenethicillin with a placebo in buccal bone-grafting proce-
dures found a high infection rate (40%) at the receptor site
in the placebo group. This indicates that antibiotic prophy-
laxis maybe beneficial in these procedures [53]. These results,
however, should be interpreted with caution since the num-
ber of patients included in this pilot study was small. It is
not known specifically how antibiotics are used in everyday
practice. Empiric prophylactic and antibiotic usage varies by
country, region, choice of antibiotic, and the duration of the
prophylaxis. This is not unexpected considering the weak sci-
entific evidence. Thus, while there is considerable disagree-
ment as to the type and length of the antibiotic prophylaxis,
the most common misuse of prophylactic antibiotics is
believed to be excessive duration [57].
The WHO suggests that unnecessary use of antibiotics for
infections is one of the main etiological factors behind anti-
biotic resistance [58]. Even a single dose of antibiotic prophy-
laxis has been shown to induce a selection of resistant
strains in the oral microflora [9], illustrating that any dosage
and its consequences should be carefully considered.
Antibiotic-resistant bacteria have become a major public
health crisis and a threat to both global stability and national
security [58]. At the same time, it is not possible to develop
and manufacture new antibiotics to satisfy the increasing
demand, resulting in an irreversible phenomenon that is dif-
ficult to manage [59]. The present unnecessary use of com-
mon antibiotics may result in both expensive future
antibiotics and an increase in bacterial resistance. Therefore,
the need for recommendations to limit and optimise the util-
isation of antibiotics are needed.
Limitations
The restriction in English language might potentially have
resulted in missed relevant studies, which is a limitation in
this review.
There were no signs indicating publication bias in the pre-
sent review, yet there is a possibility that small negative
studies might not have been published.
Conclusion
In conclusion, the scientific evidence regarding the use of
antibiotic prophylaxis for reducing the risk of infection at
bone augmentation procedures and subsequent dental
implant placement is very limited. Infection rate has been
shown to be low using a single dose of prophylactic antibi-
otics. However, the infection rate in comparison to nonusage
of prophylactic antibiotics, the compound, and the duration
of prophylactic treatment is still not known. Therefore, there
is an urgent need for further primary RCTs.
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